BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 26094531)

  • 1. Interleukin 2 as a potential cancer marker in patients after kidney transplantation.
    Witkowska A; Zywiec J; Strozik A; Gorczynska-Kosiorz S; Trautsolt W; Strzalka-Mrozik B; Kimsa M; Owczarek A; Stępień B; Mazurek U; Grzeszczak W; Gumprecht J
    Ann Agric Environ Med; 2015; 22(2):320-4. PubMed ID: 26094531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic association of tumor necrosis factor-β, interleukin-10, and interleukin-1 gene cluster polymorphism with susceptibility to pneumonia in kidney transplant recipients.
    Wan QQ; Li JL; Ye QF; Zhou JD
    Transplant Proc; 2013; 45(6):2211-4. PubMed ID: 23953530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL1B and DEFB1 Polymorphisms Increase Susceptibility to Invasive Mold Infection After Solid-Organ Transplantation.
    Wójtowicz A; Gresnigt MS; Lecompte T; Bibert S; Manuel O; Joosten LA; Rüeger S; Berger C; Boggian K; Cusini A; Garzoni C; Hirsch HH; Weisser M; Mueller NJ; Meylan PR; Steiger J; Kutalik Z; Pascual M; van Delden C; van de Veerdonk FL; Bochud PY; ;
    J Infect Dis; 2015 May; 211(10):1646-57. PubMed ID: 25398456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic association of interleukin-2, interleukin-4, interleukin-6, transforming growth factor-β, tumour necrosis factor-α and blood concentrations of calcineurin inhibitors in Turkish renal transplant patients.
    Seyhun Y; Ciftci HS; Kekik C; Karadeniz MS; Tefik T; Nane I; Turkmen A; Oguz FS; Aydin F
    Int J Immunogenet; 2015 Jun; 42(3):147-60. PubMed ID: 25817300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rejection quantity in kidney transplant recipients is associated with increasing intracellular interleukin-2 in CD8+ T-cells.
    Akoglu B; Lafferton B; Kalb S; Yosuf SE; Herrmann E; Zeuzem S; Goßmann J; Kachel HG; Scheuermann EH; Faust D
    Transpl Immunol; 2014 Jun; 31(1):17-21. PubMed ID: 24887424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of polymorphisms in the IL1B and IL2 genes with susceptibility and severity of systemic sclerosis.
    Mattuzzi S; Barbi S; Carletto A; Ravagnani V; Moore PS; Bambara LM; Scarpa A
    J Rheumatol; 2007 May; 34(5):997-1004. PubMed ID: 17444587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pentraxin 3 and C-reactive protein as inflammatory markers after a kidney transplant.
    Gursu M; Celik K; Ozturk S; Turkmen A; Gorcin S; Kocak B; Sari S; Koldas M; Feyizoglu H; Kazancioglu R
    Exp Clin Transplant; 2014 Aug; 12(4):295-9. PubMed ID: 24568622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Risk factors of acute rejection in sensitized kidney transplant recipients].
    Huang XE; Fan LP; Li LY; Zhao M; Xia SS
    Di Yi Jun Yi Da Xue Xue Bao; 2004 Oct; 24(10):1188-91. PubMed ID: 15485797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. De novo malignancies in renal transplant recipients: experience at a single center with 1882 transplant patients over 39 yr.
    Apel H; Walschburger-Zorn K; Häberle L; Wach S; Engehausen DG; Wullich B
    Clin Transplant; 2013; 27(1):E30-6. PubMed ID: 23278453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronologically different incidences of post-transplant malignancies in renal transplant recipients: single center experience.
    Ju MK; Joo DJ; Kim SJ; Huh KH; Kim MS; Jeon KO; Kim HJ; Kim SI; Kim YS
    Transpl Int; 2009 Jun; 22(6):644-53. PubMed ID: 19220824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Malignancy after renal transplantation: a single-center experience.
    Vrotniakaite K; Jaceviciute R; Rudminiene I; Laucyte-Cibulskiene A; Rainiene T; Jankevicius F; Zelvys A; Miglinas M
    Ann Transplant; 2014 Sep; 19():456-63. PubMed ID: 25223375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytokine polymorphisms and risk of infection after kidney transplantation.
    Rodrigo E; Sánchez-Velasco P; Ruiz JC; Fernández-Fresnedo G; López-Hoyos M; Piñera C; Palomar R; Gómez-Alamillo C; González-Cotorruelo J; Leyba-Cobián F; Arias M
    Transplant Proc; 2007 Sep; 39(7):2219-21. PubMed ID: 17889143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined introduction of anti-IL2 receptor antibodies, mycophenolic acid and tacrolimus: effect on malignancies after renal transplantation in a single-centre retrospective cohort study.
    Braconnier P; Del Marmol V; Broeders N; Kianda M; Massart A; Lemy A; Ghisdal L; Le Moine A; Madhoun P; Racapé J; Abramowicz D; Wissing KM
    Nephrol Dial Transplant; 2012 Jun; 27(6):2547-53. PubMed ID: 22123748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunological monitoring of calcineurin inhibitors for predicting cytomegalovirus infection in kidney transplant recipients.
    Couzi L; Thiébaut R; Carron JC; Moreau JF; Merville P; Taupin JL
    Transplantation; 2008 Oct; 86(8):1060-7. PubMed ID: 18946343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Malignancy following renal transplantation.
    Yang TC; Shu KH; Cheng CH; Wu MJ; Lian JD
    Zhonghua Yi Xue Za Zhi (Taipei); 1998 May; 61(5):281-8. PubMed ID: 9650432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Metabolic disorders in renal transplant recipients].
    Mikolasević I; Jelić I; Sladoje-Martinović B; Orlić L; Zivcić-Cosić S; Vuksanović-Mikulicić S; Mijić M; Racki S
    Acta Med Croatica; 2012 Jul; 66(3):235-41. PubMed ID: 23441539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term kinetics of a T-lymphocytes subset in kidney transplant recipients: relationship with posttransplant malignancies.
    Glowacki F; Al Morabiti M; Lionet A; Labalette M; Provot F; Noel C; Hazzan M
    Transplant Proc; 2009 Oct; 41(8):3323-5. PubMed ID: 19857742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of cyclosporin A on DNA repair and cancer incidence in kidney transplant recipients.
    Herman M; Weinstein T; Korzets A; Chagnac A; Ori Y; Zevin D; Malachi T; Gafter U
    J Lab Clin Med; 2001 Jan; 137(1):14-20. PubMed ID: 11150019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progression of hepatic histopathology in kidney transplant recipients with chronic hepatitis C virus infection and effect of immunosuppression on the course of hepatitis C virus infection.
    Korkmaz M; Fakı S; Öcal S; Harmancı Ö; Selçuk H; Haberal M
    Exp Clin Transplant; 2015 Apr; 13 Suppl 1():159-64. PubMed ID: 25894147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacodynamic immune monitoring of NFAT-regulated genes predicts skin cancer in elderly long-term renal transplant recipients.
    Sommerer C; Hartschuh W; Enk A; Meuer S; Zeier M; Giese T
    Clin Transplant; 2008; 22(5):549-54. PubMed ID: 18394001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.